ADCYAP1 and prostate neoplasm: The multifaceted nature of PACAP’s impact is highlighted, elucidating that opposite effects can emerge within the same cell line depending on factors such as exposure time, like in the case of LNCaP human prostatic tumor cells [70], or concentration, like in the case of Y-79 human retinoblastoma cells [66].